Ticker: NPCE

NeuroPace, Inc. (NASDAQ: NPCE) - quick read on what's happening inside the company and the income statement. Snapshot - facts & figures (as reported, all $ in thousands unless noted) * Q2 2025 revenue: $23,520 (up 22% vs Q2 2024); 6‑month revenue: $46,044 (up 23% YoY). * Q2 2025 gross profit: $18...

NeuroPace, Inc. (NASDAQ: NPCE) is primarily focused on transforming epilepsy treatment through its innovative RNS System. Recent financial results indicate growth in revenue but persistent net losses, alongside significant operational changes. Key Financial Highlights: Revenue: $22.5 million in ...